We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Diabetics using LifeScan’s Bluetooth-connected blood glucose monitor (BGM) in conjunction with a diabetes management digital app experienced better blood sugar control, lowered hyperglycemic readings, and significantly reduced mean glucose, the company reported in the Journal of Diabetes and Technology. Read More
Stroke-specific machine learning algorithms were no better at predicting stroke risk than self-reported risk factors and were worse in predicting stroke risk in Black patients than in White patients, according to a new study published in JAMA Network.
A new study published in the journal BMJ Open Ophthalmology shows that an artificial intelligence algorithm can successfully predict the future development of diabetic retinopathy (DR) in patients without current diagnosable symptoms. Read More
Healthcare analytics company Aetion has entered into a five-year collaboration with the FDA to use its Aetion Evidence Platform (AEP) to analyze novel oncology real-world data and answer questions about cancer prevention, clinical care, diagnostics and treatment.
In a postmarket study, Vasc-Alert’s surveillance technology successfully identified high-risk dialysis patients, a group seven times more likely to experience blood vessel narrowing, researchers reported in the Journal of Vascular Access.
BioIntelliSense and care.ai have teamed up to combine their existing technologies to provide continuous monitoring from medical-grade wearables to improve clinical workflows in healthcare facilities.